NCDs are the leading causes of mortality and morbidity globally, with the majority of the burden being placed on lower-middle-income countries. Data provides real-world evidence that can be harnessed to help address the disease burden of NCDs at global, national, regional, and local levels — informing health care reform and policies.

Cross-sector partnerships between governments, pharmaceutical companies, academic institutions, and other stakeholders can improve the collection and utilization of NCD data, creating a beneficial impact on the prevention, detection, and management of NCDs.

In this newsletter, have a glimpse of how Access Accelerated and our partners are working every day to tackle the NCD challenge head-on. Read more